• 1
    Rocheleau CE, Yasuda J, Shin TH, Lin R, Sawa H, Okano H, Priess JR, Davis RJ, Mello CC. WRM-1 activates the LIT-1 protein kinase to transduce anterior/posterior polarity signals in C. elegans. Cell 1999; 97: 71726.
  • 2
    Meneghini MD, Ishitani T, Carter JC, Hisamoto N, Ninomiya-Tsuji J, Thorpe CJ, Hamill DR, Matsumoto K, Bowerman B. MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans. Nature 1999; 399: 7937.
  • 3
    Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, Matsumoto K. The TAK1-NLK-MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF. Nature 1999; 399: 798802.
  • 4
    Verheyen EM, Mirkovic I, MacLean SJ, Langmann C, Andrews BC, MacKinnon C. The tissue polarity gene nemo carries out multiple roles in patterning during Drosophila development. Mech Dev 2001; 101: 11932.
  • 5
    Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT. The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 2000; 16: 27983.
  • 6
    Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/β-catenin signaling. Mol Cell Biol 2003; 23: 1319.
  • 7
    Ishitani T, Ninomiya-Tsuji J, Matsumoto K. Regulation of lymphoid enhancer factor 1 /T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol 2003; 23: 137989.
  • 8
    Kaletta T, Schnabel H, Schnabel R. Binary specification of the embryonic lineage in Caenorhabditis elegans. Nature 1997; 390: 2948.
  • 9
    Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999; 9: 1521.
  • 10
    Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 2000; 287: 16069.
  • 11
    Yasuda J, Tsuchiya A, Yamada T, Sakamoto M, Sekiya T, Hirohashi S. Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells. Biochem Biophys Res Commun 2003; 308: 22733.
  • 12
    Naishiro Y, Yamada T, Takaoka AS, Hayashi R, Hasegawa F, Imai K, Hirohashi S. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of β-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res 2001; 61: 27518.
  • 13
    van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111: 24150.
  • 14
    Mirkovic I, Charish K, Gorski SM, McKnight K, Verheyen EM. Drosophila nemo is an essential gene involved in the regulation of programmed cell death. Mech Dev 2002; 119: 920.
  • 15
    Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A. Inhibition of JNK activation through NF-kB target genes. Nature 2001; 414: 3137.
  • 16
    de Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G. Induction of gadd45beta by NF-?B downregulates pro-apoptotic JNK signalling. Nature 2001; 414: 30813.
  • 17
    Karin M, Lin A. NF-?B at the crossroads of life and death. Nat Immunol 2002; 3: 2217.
  • 18
    Chen F, Castranova V, Shi X. New insights into the role of nuclear factor-?B in cell growth regulation. Am J Pathol 2001; 159: 38797.
  • 19
    Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nature Rev Cancer 2002; 2: 3847.
  • 20
    Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin AS Jr. Requirement of NF-?B activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 1997; 278: 18125.
  • 21
    Joneson T, Bar-Sagi D. Suppression of Ras-induced apoptosis by the Rac GTPase. Mol Cell Biol 1999; 19: 5892901.
  • 22
    Casares S, Ionov Y, Ge HY, Stanbridge E, Perucho M. The microsatellite mutator phenotype of colon cancer cells is often recessive. Oncogene 1995; 11: 230310.
  • 23
    Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 1997; 94: 292732.
  • 24
    Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ. Regulation of NF-?B by cyclin-dependent kinases associated with the p300 coactivator. Science 1997; 275: 5237.
  • 25
    Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-?B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998; 1: 66171.
  • 26
    Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-?B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002; 9: 62536.
  • 27
    Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996; 85: 40314.
  • 28
    Miyazono K. Positive and negative regulation of TGF-β signaling. J Cell Sci 2000; 113 Pt 7: 11019.
  • 29
    Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 1997; 89: 117584.
  • 30
    Gu W, Shi XL, Roeder RG. Synergistic activation of transcription by CBP and p53. Nature 1997; 387: 81923.
  • 31
    Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM. Binding and modulation of p53 by p300/CBP coactivators. Nature 1997; 387: 8237.
  • 32
    El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 81725.
  • 33
    Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998; 17: 3091100.
  • 34
    Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993; 365: 8559.
  • 35
    Kitabayashi I, Aikawa Y, Nguyen LA, Yokoyama A, Ohki M. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J 2001; 20: 718496.
  • 36
    Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SG, Green MR, Goodman RH. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994; 370: 2236.
  • 37
    Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD, Davis RJ. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 1997; 17: 236071.
  • 38
    Iizuka M, Stillman B. Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein. J Biol Chem 1999; 274: 2302734.
  • 39
    Baeuerle PA, Baltimore D. I ?B: a specific inhibitor of the NF-?B transcription factor. Science 1988; 242: 5406.
  • 40
    Baeuerle PA, Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-?B transcription factor. Cell 1988; 53: 2117.
  • 41
    Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev 2000; 14: 155377.
  • 42
    Chan HM, La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 2001; 114: 236373.
  • 43
    Bannister AJ Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996; 384: 6413.
  • 44
    Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996; 87: 9539.
  • 45
    Hecht A, Vleminckx K, Stemmler MP, van Roy F, Kemler R. The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates. EMBO J 2000; 19: 183950.
  • 46
    Miyagishi M, Fujii R, Hatta M, Yoshida E, Araya N, Nagafuchi A, Ishihara S, Nakajima T, Fukamizu A. Regulation of Lef-mediated transcription and p53-dependent pathway by associating β-catenin with CBP/p300. J Biol Chem 2000; 275: 351705.
  • 47
    Sun Y, Kolligs FT, Hottiger MO, Mosavin R, Fearon ER, Nabel GJ. Regulation of β-catenin transformation by the p300 transcriptional coactivator. Proc Natl Acad Sci USA 2000; 97: 126138.
  • 48
    Takemaru KI, Moon RT. The transcriptional coactivator CBP interacts with β-catenin to activate gene expression. J Cell Biol 2000; 149: 24954.
  • 49
    Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T. Acetylation of β-catenin by CBP. J Biol Chem 2002; 277: 225627.
  • 50
    Akimaru H, Hou DX, Ishii S. Drosophila CBP is required for dorsal-dependent twist gene expression. Nat Genet 1997; 17: 2114.
  • 51
    Brott BK, Pinsky BA, Erikson RL. Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proc Natl Acad Sci USA 1998; 95: 9638.
  • 52
    Kitabayashi I, Eckner R, Arany Z, Chiu R, Gachelin G, Livingston DM, Yokoyama KK. Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1 A during the differentiation of F9 cells. EMBO J 1995; 14: 3496509.
  • 53
    Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP, Tao S, Lin Q, Kubo Y, Khavari PA. NF-?B blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003; 421: 63943.
  • 54
    Kortenjann M, Wehrle C, Nehls MC, Boehm T. Only one nemo-like kinase gene homologue in invertebrate and mammalian genomes. Gene 2001; 278: 1615.